Informations bibliographiques
Ligne directriceWHO recommendations on the management of sickle cell disease during pregnancy, childbirth and the interpregnancy period
Année de publication2025
Institution émettriceWorld Health Organization
Recommandation
Nouvelle
For pregnant women with sickle-cell disease (SCD) without complications (due to SCD or to obstetric causes), offer growth/biometric scans to identify fetal growth restriction every four weeks from 24 until 32 weeks’ gestation, and then every three weeks until birth.
Recommandé